(Q37947960)

25 August 2017

title

Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer (English)

1 reference

25 August 2017

0 references

1 reference

Naveena B Janakiram

1

1 reference

25 August 2017

Altaf Mohammed

series ordinal

2

1 reference

25 August 2017

Chinthalapally V Rao

series ordinal

3

1 reference

25 August 2017

publication date

1 December 2011

1 reference

Cancer and Metastasis Reviews

25 August 2017

published in

1 reference

25 August 2017

volume

30

1 reference

25 August 2017

issue

3-4

1 reference

25 August 2017

page(s)

507-523

1 reference

https://scigraph.springernature.com/pub.10.1007/s10555-011-9311-2

25 August 2017

exact match

0 references

cites work

New insights into the aetiology of colorectal cancer from genome-wide association studies

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Mechanisms of disease: chronic inflammation and cancer in the pancreas--a potential role for pancreatic stellate cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Genetic progression in the pancreatic ducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Epidemiology of pancreatic cancer: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Inflammation and pancreatic cancer: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

NSAIDs and chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Cyclooxygenase-2 and colorectal cancer chemoprevention: the beta-catenin connection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

G-protein-coupled receptors and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Clinicopathological correlations of cyclooxygenase-2, MDM2, and p53 expressions in surgically resectable pancreatic invasive ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Cyclooxygenase-2 modulates the insulin-like growth factor axis in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Inhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

The deregulation of arachidonic acid metabolism-related genes in human esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Multiple signal pathways are involved in the mitogenic effect of 5(S)-HETE in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

A novel anti-pancreatic cancer agent, LY293111.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Randomized double-blind phase II trial comparing gemcitabine plus LY293111 versus gemcitabine plus placebo in advanced adenocarcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Collagen-induced arthritis is reduced in 5-lipoxygenase-activating protein-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Altered inflammatory responses in leukotriene-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Protection from pulmonary fibrosis in leukotriene-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Allergic lung responses are increased in prostaglandin H synthase-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

12-lipoxygenase metabolite 12(S)-HETE stimulates human pancreatic cancer cell proliferation via protein tyrosine phosphorylation and ERK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Selective incorporation of (15S)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: agonist-induced deacylation and transformation of stored hydroxyeicosanoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Lipoxins: potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Effects of lipoxin A(4) on CoCl(2)-induced angiogenesis and its possible mechanisms in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

ATL-1, an analogue of aspirin-triggered lipoxin A4, is a potent inhibitor of several steps in angiogenesis induced by vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Signal pathway involved in inhibition by lipoxin A(4) of production of interleukins induced in endothelial cells by lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Diminished lipoxin biosynthesis in severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Role of prostacyclin in the cardiovascular response to thromboxane A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Resolvin E1 reduces proinflammatory markers in human pancreatic islets in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Role of plant-derived omega-3 fatty acids in human nutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Omega-3 fatty acids as cancer chemopreventive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Cox-2 inhibitory effects of naturally occurring and modified fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Inhibition of prostaglandin biosynthesis by eicosapentaenoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Modulation of tissue prostaglandin synthesizing capacity by increased ratios of dietary alpha-linolenic acid to linoleic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Regulatory potential of n-3 fatty acids in immunological and inflammatory processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Protein kinase C betaII and TGFbetaRII in omega-3 fatty acid-mediated inhibition of colon carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Overexpression of protein kinase C betaII induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Altered regulation of TGF-beta 1 and TGF-alpha in primary keratinocytes and papillomas expressing v-Ha-ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Inflammatory mechanisms contributing to pancreatic cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Regulation of interleukin-8 expression by nitric oxide in human pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Lymphocytes stimulate expression of 5-lipoxygenase and its activating protein in monocytes in vitro via granulocyte macrophage colony-stimulating factor and interleukin 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Leukotrienes and lipoxins--new potential performers in the regulation of human myelopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Expression of chemokines and chemokine receptors in human colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Platelet-activating factor and related lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Platelet-activating factor-induced NF-kappaB activation enhances VEGF expression through a decrease in p53 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

Expression of galectin-3 in the tumor immune response in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9311-2

10.1007/S10555-011-9311-2

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference